Might erectile dysfunction be due to the thermolabile variant of methylenetetrahydrofolate reductase?

Journal of Endocrinological Investigation

Volumn 27, Issue 9, 2004, Pages 883-885

  Lombardo, Francesco ^a   Sgro P ^a   Gandini, L ^a   Dondero, F ^a   Jannini, E A ^b   Lenzi, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Erectile dysfunction; Hyperhomocysteinemia; MTHFR thermolabile variant; PDE5 inhibitor

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PROSTAGLANDIN E1; SILDENAFIL;

ADULT; ARTICLE; BLOOD LEVEL; CASE REPORT; COLOR ULTRASOUND FLOWMETRY; ERECTILE DYSFUNCTION; FOLLOW UP; GENETIC ANALYSIS; HETEROSEXUALITY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PENIS ARTERY; SEXUAL INTERCOURSE; SYMPTOMATOLOGY;

EID: 14544284657     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346286     Document Type: Article

References (15)

1. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10: 111-13.
2. Tawacol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997, 95: 1119-21.
3. Madonna P, de Stefano V, Coppola A, et al. Hyperhomocysteinemia and other inherited prothrombotic conditions in young adults with a history of ischemic stroke. Stroke 2002, 33: 51-6.
4. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM. A prospective study of plasma homocysteine and risk of myocardial infarction in US physician. JAMA 1992, 268: 877-81.
5. Ikeda U, Ikeda M, Minota S, Shimada K. Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells. Circulation 1999, 99: 1230-35.
6. Chao CL, Kuo TL, Lee YT. Effects of methionine-induced hyperhomocysteinemia on endothelium-dependent vasodilation and oxidative status in healthy adults. Circulation 2000, 101: 485-90.
7. Nelen WL. Hyperhomocysteinaemia and human reproduction. Clin Chem Lab Med 2001, 39: 758-63.
8. Speel TG, van Langen H, Meuleman EJ. The risk of coronary heart disease in men with erectile dysfunction. Eur Urol 2003, 44: 366-70.
9. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multimensional scale for assessment of erectile dysfunction. Urology 1997, 49: 822-30.
10. Nakata Y, Katsuya T, Takami S, et al. Methylenetetrahydrofolate reductase gene polymorphism: relation to blood pressure and cerebrovascular disease. Am J Hypertens 1998, 11: 1019-23.
11. Rosemberg LE. Inherited disorders of amino acid metabolism and storage. In: Harrison's Principles of Internal Medicine. 13th ed. New York: McGraw-Hill. 1994, 2117-2125.
12. Carosa E, Benvenga S, Trimarchi F, et al. Lack of sexual activity for erectile dysfunction causes a reversible reduction of LH bioavability. Int J Impot Res 2002, 14: 93-9.
13. Welch GN, Upchurch GR Jr, Loscalzo J. Homocysteine, oxidative stress, and vascular disease. Hosp Pract (Off Ed). 1997, 32: 81-82.
14. Fu WY, Dudman NP, Perry MA, Wang XL. Homocysteine attenuates hemodynamic responses to nitric oxide in vivo. Atherosclerosis 2002, 161: 169-76.
15. Ubbink JB, Vermaak WJH, Van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 1993, 57: 47-3.